|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 750 9th Street, NW |
Address2 | SUITE 500 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 17933-00012
|
||||||||
|
6. House ID# 312630000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: DAVID WIERMANSKI |
Date | 4/19/2017 1:31:46 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 181 Close Annuity Loopholes in Medicaid Act
H.R. 184 Protect Medical Innovation Act
H.R. 246 Jobs and Premium Protection Act
S. 183 Jobs and Premium Protection Act
H.R. 284 Advancing Medical Resident Training in Community Hospitals Act
H.R. 309 National Clinical Care Commission Act
H.R. 372 Competitive Health Insurance Reform Act
H.R. 592 Pharmacy and Medically Underserved Areas Enhancement Act
S. 109 Pharmacy and Medically Underserved Areas Enhancement Act
H.R. 741 Rural Hospital Regulatory Relief Act
S. 243 Rural Hospital Regulatory Relief Act
H.R. 766 Amend Title XVII of the Social Security Act to expand telehealth in Medicare
H.R. 829 Prioritizing the Most Vulnerable Over Lottery Winners Act
H.R. 849/ S. 260 Protecting Seniors' Access to Medicare Act
H.R. 998 Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act
H.R. 1004 Regulatory Integrity Act
H.R. 1009 OIRA Insight, Reform, and Accountability Act
S. 676 OIRA Insight, Reform, and Accountability Act
H.R. 1038 Improving Transparency and Accuracy in Medicare Part D Spending
S. 413 Improving Transparency and Accuracy in Medicare Part D Spending
H.R. 1072/ S. 222 Obamacare Replacement Act
H.R. 1101 Small Business Health Fairness Act of 2017
H.R. 1121 Pre-Existing Conditions Protection Act of 2017
H.R. 1148/S. 431 Furthering Access to Stroke Telemedicine (FAST) Act
H.R. 1215 Protecting Access to Care Act
H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act
H.R. 1267/S. 482 (PHIT Act)
H.R. 1304 Self-Insurance Protection Act
H.R. 1313 Preserving Employee Wellness Programs Act
H.R. 1554/S. 581 Jessie's Law
H.R. 1565 Saving Lives, Saving Costs Act
H.R. 1628 American Health Care Act
H.R. 1776/ S. 771 Improving Access to Affordable Prescription Drugs Act
Pub. L. 102-143 Telephone Consumer Protection Act
Pub. L. 111-5, The American Recovery and Reinvestment Act
Pub. L. 111-148 Patient Protection and Affordable Care Act (PPACA)
Pub. L. 114-10 Medicare Access and CHIP Reauthorization Act (MACRA)
P.L. 114-198 Comprehensive Addiction and Recovery Act
Pub. L. 114-255, 21st Century Cures Act
Pub. L. 114-270 Expanding Capacity for Health Outcomes Act (ECHO)
Pub. L. 114-328, National Defense Authorization Act for Fiscal Year
Pub. L. 114-329 American Innovation and Competitiveness Act
S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act
S. 64 Safe and Affordable Drugs from Canada Act
S. 108 Medical Debvice Access and Innovation Protection Act
S. 191 Patient Freedom Act
S. 251 Protecting Medicare from Executive Action Act
S. 464 Independence at Home Act
S. 761 Health Care Options Act of 2017
S. 787, Telehealth Innovation and Improvement Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Grealy |
|
|
|
Debbie |
Witchey |
|
|
|
Michael |
Freeman |
|
|
|
Tina |
Grande |
|
|
|
Amanda |
Uherek |
|
|
|
Christopher |
Adamec |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 181 Close Annuity Loopholes in Medicaid Act
H.R. 184 Protect Medical Innovation Act
H.R. 284 Advancing Medical Resident Training in Community Hospitals Act
H.R. 741 Rural Hospital Regulatory Relief Act
S. 243 Rural Hospital Regulatory Relief Act
H.R. 766 Amend Title XVII of the Social Security Act to expand telehealth in Medicare
H.R. 849 Protecting Seniors' Access to Medicare Act
S. 260 Protecting Seniors' Access to Medicare Act
H.R. 1038 Improving Transparency and Accuracy in Medicare Part D Spending
S. 413 Improving Transparency and Accuracy in Medicare Part D Spending
H.R. 1148 Furthering Access to Stroke Telemedicine (FAST) Act
S. 431 Furthering Access to Stroke Telemedicine (FAST) Act
H.R. 1245 Affordable and Safe Prescription Drug Importation Act
S. 469 Affordable and Safe Prescription Drug Importation Act
H.R. 1628 American Health Care Act
H.R. 1776 Improving Access to Affordable Prescription Drugs Act
S. 771 Improving Access to Affordable Prescription Drugs Act
Pub. L. 114-10 Medicare Access and CHIP Reauthorization Act (MACRA)
S. 64 Safe and Affordable Drugs from Canada Act
S. 108 Medical Debvice Access and Innovation Protection Act
S. 251 Protecting Medicare from Executive Action Act
S. 464 Independence at Home Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Congressional Budget Office (CBO), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Grealy |
|
|
|
Debbie |
Witchey |
|
|
|
Michael |
Freeman |
|
|
|
Tina |
Grande |
|
|
|
Amanda |
Uherek |
|
|
|
Christopher |
Adamec |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |